MotherToBaby

MotherToBaby, a service of the non-profit Organization of Teratology Information Specialists (OTIS), has been dedicated to understanding the effects of environmental agents in maternal and fetal/infant health since its founding in 1987. It aims to prevent negative pregnancy outcomes, including birth defects, and communicate evidence-based information about medications and other exposures in pregnancy and lactation. The company provides up-to-date information to pregnant and lactating women and health care professionals, empowering them to make informed treatment choices. Additionally, MotherToBaby works to reduce risks and prevent birth defects by educating the public and healthcare providers about specific agents of concern. Moreover, the company conducts MotherToBaby Pregnancy Studies, observational studies that focus on evaluating the safety in pregnancy of medications and vaccines. MotherToBaby recently received a grant investment on 01 October 2023 from the Centers for Disease Control and Prevention. The company operates in the Health Care and Women's Health industries, contributing significantly to research and the worldwide literature in the field of teratology. With its mission to provide accurate information and prevent unnecessary terminations of wanted pregnancies, MotherToBaby supports a critical niche in the health and maternal wellness sector.